Detalles de la búsqueda
1.
Effect of avalglucosidase alfa on disease-specific and general patient-reported outcomes in treatment-naïve adults with late-onset Pompe disease compared with alglucosidase alfa: Meaningful change analyses from the Phase 3 COMET trial.
Mol Genet Metab
; 141(2): 108121, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184428
2.
Validation of a scoring algorithm for the clinician-reported outcome tool 'prurigo activity and severity (PAS)' based on clinical studies of dupilumab in adults with prurigo Nodularis.
J Eur Acad Dermatol Venereol
; 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38563058
3.
Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study.
Eur Respir J
; 62(5)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734856
4.
Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study.
J Asthma
; 60(5): 981-990, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36066123
5.
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study.
Allergol Int
; 72(1): 89-99, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36114102
6.
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
Allergy
; 77(7): 2211-2221, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35034364
7.
How a concentration-effect analysis of data from the eliglustat thorough electrocardiographic study was used to support dosing recommendations.
Mol Genet Metab
; 131(1-2): 211-218, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33012655
8.
Model averaging inconcentration-QT analyses.
Pharm Stat
; 15(6): 450-458, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27492846
9.
Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis: Pooled results from the LIBERTY AD SOLO clinical trials.
J Am Acad Dermatol
; 83(5): 1499-1501, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32504724
10.
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.
Otolaryngol Head Neck Surg
; 170(4): 1173-1182, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38156522
11.
Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic Asthma.
J Allergy Clin Immunol Pract
; 11(3): 873-884.e11, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36572184
12.
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps.
Clin Transl Immunology
; 12(1): e1433, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36721661
13.
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial.
J Asthma Allergy
; 16: 323-332, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37016622
14.
Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma.
Respir Med
; 218: 107344, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37659435
15.
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma.
Respir Med
; 191: 105991, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090688
16.
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study.
J Asthma Allergy
; 15: 767-773, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35698581
17.
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps.
Int Forum Allergy Rhinol
; 11(7): 1087-1101, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33611847
18.
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
J Allergy Clin Immunol Pract
; 9(6): 2461-2471.e5, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33548517
19.
Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials.
Dermatol Ther (Heidelb)
; 11(4): 1357-1372, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34142350
20.
High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab.
Arthritis Res Ther
; 22(1): 250, 2020 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33081825